VitalCare Diabetes Treatment Centers, Inc., a Nevada Corporation, today announced the national launch for opening licensed diabetes treatment centers utilizing the micro-dose intravenous insulin pump technology together with proprietary algorithms and clinical protocols for providing Intercellular Activation Therapy (iCAT) for treating diabetes.
The iCAT treatment is currently being administered at several clinics in Arizona, Nevada, Utah, Florida, Texas and Puerto Rico, to those who suffer from Type 1 and Type 2 Diabetes, in addition to secondary complications of Type 2 Diabetes including hypertension, peripheral vascular disease, retinopathy, heart disease, peripheral neuropathy, kidney disease, and diabetic wounds.
Jimmy McDougald, CEO, stated, “Due to VitalCare’s clinical specialists’ succeeding in the treatment of Type 1, Type 2 and Secondary Complications of Type 2 Diabetes over the past two decades, our executive board has decided to open opportunities for licensing VitalCare Diabetes Treatment Centers affiliates with certified training for qualified healthcare providers, for the licensing and use of iCAT Therapy. It is VitalCare’s goal to make iCAT Therapy more accessible to the 21 million diabetics in North America. The VitalCare Diabetes Treatment Centers will either be company owned, joint ventured or licensed to select qualified medical professionals.”
No Comment Received
Leave A Reply